Tobramycin

Acute Application of Antibiotic Powder in Open Fracture Wounds

Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified

Antibiotic Loaded Cement After TKA

Locally Applied Antibiotics for Infection Prophylaxis in Treatment of Open Fractures

IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy

Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive Agents

Topical Antibiotics in Chronic Rhinosinusitis

Effect of Various Treatment Modalities on Dendritic Vial Ulcer

DPI-Tobra-Kind Cyclops® in Children With Cystic Fibrosis

Tobramycin Administered at the Beginning of Dialysis

A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®

Study for Antibiotic Impregnated Calcium Sulfate Beads as Prophylaxis for Surgical Site Infection

Pharmacokinetic and Pharmacoscintigraphic Comparison of TobrAir® 6.0 With TOBI® and TOBI® Podhaler™

Pharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled Tobramycin

Once Daily Aminoglycoside Pharmacokinetics and Optimal Dosing in the Burn Population: A Prospective Study

Antibiotic Nephrotoxicity in Adult Patients With Cystic Fibrosis

Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis

Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis

Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis Bronchiectasis

Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children.